Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses

Citation
F. Simon et al., Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses, AIDS RES H, 17(10), 2001, pp. 937-952
Citations number
70
Categorie Soggetti
Immunology
Journal title
AIDS RESEARCH AND HUMAN RETROVIRUSES
ISSN journal
08892229 → ACNP
Volume
17
Issue
10
Year of publication
2001
Pages
937 - 952
Database
ISI
SICI code
0889-2229(200107)17:10<937:SPSFTD>2.0.ZU;2-C
Abstract
We developed a simple, rapid, inexpensive, and highly sensitive and specifi c strategy for the detection and lineage differentiation of primate lentivi ruses (PIV-ELISA). It is based on the use of two indirect ELISA methods usi ng synthetic peptides mapping the gp41/36 region (detection component) and the V3 region (differentiation component) of four lentivirus lineages, name ly SIVcpz/HIV-1 (groups M, O, N, and SIVcpz-gab), SIVmnd, SIVagm, and SIVsm /SIVmac/HIV-2. This strategy was evaluated with panels of sera originating from both humans and nonhuman primates. The human reference panel consisted of 144 HIV Western blot (WB)-positive sera in which the corresponding viru s had been genotyped (HIV-1: 72 group M, 28 group O, and 6 group N; HIV-2: 21 subtype A and 10 subtype B; and 7 HIV-1+2) and 105 HIV WB-negative sampl es. The nonhuman primate reference panel consisted of 24 sera from monkeys infected by viruses belonging to the four lineages included in the PIV-ELIS A strategy (5 chimpanzees, 5 macaques, 8 mandrills, and 6 vervets) and 42 s amples from seronegative animals. Additional field evaluation panels consis ted of 815 human sera from Gabon, Cameroon, and France and 537 samples from 25 nonhuman primate species. All the samples from the two reference panels were correctly detected and discriminated by PIV-ELISA. In the human field evaluation panel, the gp41/36 component correctly identified all the test samples, with 98% specificity. The V3 component discriminated 206 HIV-1 gro up M, 98 group O, 12 group M+O, and 128 HIV-2 sera. In the primate field ev aluation panel, both gp41/36 and V3 detected and discriminated all the WB-p ositive samples originating from monkeys infected with SIVcpz, SIVagm-ver, SIVmnd-1, SIVmnd-2, SIVdrl, or SIVsun. These results were confirmed by geno typing in every case. Four SIV-infected red-capped mangabeys (confirmed by PCR) were correctly identified by gp41/36, but only two reacted with the V3 peptides in the absence of a specific SIVrcm V3 peptide. Addition of a V3 SIVrcm peptide discriminated all the SIVrcm-positive samples. Fourteen Papi o papio samples were positive for SIVsm gp 36 and by WB, but negative by PC R, whereas three Papio cynocephalus samples were positive by gp41/36 but in determinate by WB and negative by PCR. This combined ELISA system is thus h ighly sensitive and specific for antibodies directed against HIV and SIV. I n addition, the V3-based serotyping results always agreed with genotyping r esults. This method should prove useful for studies of lentivirus prevalenc e and diversity in human and nonhuman primates, and may also have the poten tial to detect previously undescribed SIVs.